In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability

Chemistry and Biodiversity

Volumn 6, Issue 11, 2009, Pages 1845-1866

  Akamatsu, Miki ^a   Fujikawa, Masaaki ^a   Nakao, Kazuya ^b   Shimizu, Ryo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; ARTIFICIAL MEMBRANE; BIODIVERSITY; BIOSORPTION; COMPUTER MODEL; CONFERENCE PAPER; DONOR; HUMAN; HYDROGEN BOND; LIPOPHILICITY; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; PARALLEL ARTIFICIAL MEMBRANE PERMEATION ASSAY; PH; PHYSICAL CHEMISTRY; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ABSORPTION; ALGORITHMS; CACO-2 CELLS; COMPUTER SIMULATION; FORECASTING; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; MEMBRANES, ARTIFICIAL; MOUTH MUCOSA; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLUBILITY;

EID: 72449191263     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200900112     Document Type: Conference Paper

References (86)

1. I. Tamai, H. Takanaga, H. Maeda, Y. Sai, T. Ogihara, H. Higashida, A. Tsuji, Biochem. Biophys. Res. Comm. 1995, 214, 482.
2. C. Zhu, L. Jiang, T. M. Chen, K. K. Hwang, Eur. J. Med. Chem. 2002, 37, 399.
3. P. Stenberg, U. Norinder, K. Luthman, P. Artursson, J. Med. Chem. 2001, 44, 1927.
4. G. Klopman, L. R. Stefan, R. Saiakhov, Eur. J. Pharm. Sci. 2002, 17, 253.
5. N. Parrott, T. Lavé, Eur. J. Pharm. Sci. 2002, 17, 56.
6. K. Palm, K. Luthman, A.-L. Ungell, G. Strandlund, P. Artursson, J. Pharm. Sci. 1996, 85, 32.
7. F. Yoshida, J. G. Topliss, J. Med. Chem. 2002, 43, 2575.
8. M. Kobayshi, N. Sada, M. Sugawara, K. Iseki, K. Miyazaki, Int. J. Pharm. 2001, 221, 87.
9. M. D. Wessel, P. C. Jurs, J. W. Tolan, S. M. Muskal, J. Chem. Inf. Comp. Sci. 1998, 38, 726.
10. O. A. Raevsky, V. I. Fetisov, E. P. Trepalina, J. W. McFarland, K.-J. Schaper, Quant. Struct.-Act. Relat. 2000, 19, 366.
11. M. Iyer, Y. J. Tseng, C. L. Senese, J. Liu, A. J. Hopfinger, Mol. Pharmacol. 2007, 4, 218.
12. R. Liang, Y.-J. Fei, P. D. Prasad, S. Rammamoorthy, H. Han, T. L. Yang-Feng, M. A. Hediger, V. Ganapathy, F. H. Leibach, J. Biol. Chem. 1995, 270, 6456.
13. K. Ueda, M. M. Cornwell, M. M. Gottesman, I. Pastan, I. B. Roninson, V. Ling, J. R. Riordan, Biochem. Biophys. Res. Commum. 1986, 141, 956.
14. M. Kansy, F. Senner, K. Gubernator, J. Med. Chem. 1998, 41, 1007.
15. F. Wohnsland, B. Faller, J. Med. Chem. 2001, 44, 923.
16. K. Sugano, H. Hamada, M. Machida, H. Ushio, J. Biomol. Screen. 2001, 6, 189.
17. K. Sugano, N. Takata, M. Machida, K. Saitoh, K. Terada, Int. J. Pharm. 2002, 241, 241.
18. K. Sugano, Y. Nabuchi, M. Machida, Y. Aso, Int. J. Pharm. 2003, 257, 245.
19. D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward, K. D. Kopple, J. Med. Chem. 2002, 45, 2615.
20. E. H. Kerns, J. Pharm. Sci. 2001, 90, 1838.
21. L. Di, E. H. Kerns, K. Fan, O. J. McConnel, G. T. Carter, Eur. J. Med. Chem. 2003, 38, 223.
22. K. Obata, K. Sugano, M. Machida, Y. Aso, Drug Dev. Ind. Pharm. 2004, 30, 181.
23. G. Ottaviani, S. Martel, P.-A. Carrupt, J. Med. Chem. 2006, 49, 3948.
24. X. Chen, A. Murawski, K. Patel, C. L. Crespi, P. V. Balimane, Pharm. Res. 2008, 25, 1511.
25. M. Fujikawa, R. Ano, K. Nakao, R. Shimizu, M. Akamatsu, Bioorg. Med. Chem. 2005, 13, 4721.
26. M. Fujikawa, R. Nakao, R. Shimizu, M. Akamatsu, Bioorg. Med. Chem. 2007, 15, 3756.
27. R. Ano, Y. Kimura, M. Shima, R. Matsuno, T. Ueno, M. Akamatsu, Bioorg. Med. Chem. 2004, 12, 257.
28. C. Hansch, T. Fujita, J. Am. Chem. Soc. 1964, 86, 1616.
29. H. Kubinyi, Arzneim. Forsch. 1979, 29, 1067.
30. SYBYL Molecular Modeling Software, Tripos Associates, Inc., St Louis, MO, USA.
31. C. Hansch, A. Leo, in 'Exploring QSAR', Eds. C. Hansch, A. Leo, American Chemical Society, Washington, DC, 1995.
32. CLOGP, Ver. 4.0; Biobyte Corp., Claremont, CA, USA.
33. CQSAR, Biobyte Corp., Claremont, CA, USA.
34. M. Asao, R. Shimizu, K. Nakao, T. Nishioka, T. Fujita, JCPE Registered Program No. 115, Society for Computer Chemistry, Japan.
35. H. Terada, K. Kitagawa, Y. Yoshikawa, F. Kametani, Chem. Pharm. Bull. 1981, 29, 7.
36. M. Akamatsu, Y. Yoshida, H. Nakamura, M. Asao, H. Iwamura, T. Fujita, Quant. Struct.-Act. Relat. 1989, 8, 195.
37. T. Fujita, T. Nishioka, M. Nakajima, J. Med. Chem. 1977, 20, 1071.
38. A. Avdeef, P. E. Nielsen, O. Tsinman, Eur. J. Pharm. Sci. 2004, 22, 365.
39. A. Avdeef, 'Absorption and Drug Development: Solubility, Permeability, and Charge State', John Wiley & Sons, Hoboken, New Jersey, 2003.
40. K. Sugano, personal communication.
41. J. A. Ruell, K. L. Tsinman, A. Avdeef. Eur. J. Pharm. Sci. 2003, 20, 393.
42. M. Fujikawa, R. Nakao, R. Shimizu, M. Akamatsu, Chemosphere 2009, 74, 751.
43. P. Artursson, J. Karlsson, Biochem. Biophys. Res. Comm. 1991, 175, 880.
44. H. van de Waterbeemd, G. Camenisch, G. Folkers, O. A. Raevsky, Quant. Struct.-Act. Relat. 1996, 15, 480.
45. A. Kulkarni, Y. Han, A. J. Hopfinger, J. Chem. Inf. Comput. Sci. 2002, 42, 331.
46. G. Camenisch, J. Alsenz, H. van de Waterbeemd, G. Folkers, Eur. J. Pharm. Sci. 1998, 6, 313.
47. J. T. Goodwin, B. Mao, T. J. Vidmar, R. A. Conrani, P. S. Burton, J. Pept. Res. 1999, 53, 355.
48. S. Ren, E. J. Lien, Prog. Drug Res. 2000, 54, 1.
49. T. J. Hou, W. Zhang, K. Xia, X. B. Qiao, X. J. Xu, J. Chem. Inf. Comp. Sci. 2004, 44, 1585.
50. R. Ano, Y. Kimura, M. Urakami, M. Shima, R. Matsuno, T. Ueno, M. Akamatsu, Bioorg. Med. Chem. 2004, 12, 249.
51. M. Yazdanian, S. L. Glynn, J. L. Wright, A. Hawa, Pharm. Res. 1998, 15, 1490.
52. Y. Kido, I. Tamai, M. Okamoto, F. Suzuki, A. Tsuji, Pharm. Res. 2000, 17, 55.
53. T. Terao, E. Hisanaga, Y. Sai, I. Tamai, A. Tsuji, J. Pharm. Pharmacol. 1996, 48, 1083.
54. K. Lee, C. Ng Kim, L. R. Brouwer, D. R. Thakker, J. Pharm. Exp. Ther. 2002, 303, 574.
55. H. Potschka, W. Löscher, Epilepsia 2001, 42, 1231.
56. M. Cereijido, O. Ruiz, L. Gonzalez-Mariscal, R. G. Contreras, M. S. Balda, M. R. Garcia-Villegas, in 'Biological Barriers to Protein Delivery', Eds. K. L. Audus, T. Raub, Plenum Press, New York, USA, 1993, p. 3.
57. J. P. Karlsson, P. Artursson, Int. J. Pharm. 1991, 71, 55.
58. K. Nakao, M. Fujikawa, R. Shimizu, M. Akamatsu. J. Comp.-Aided Mol. Des. 2009, 23, 309.
59. W. M. Meylan, P. H. Howard, J. Pharm. Sci. 1995, 84, 83.
60. A. A. Petrauskas, E. A. Kolovanov, ACD/LogP, Vers. 10, Persp. Drug Discov. Design 2000, 19, 99.
61. miLogP, Ver. 2.2, Molinspiration Cheminformatics, Slovak Republic.
62. P. Japertas, R. Didziapetris, A. Petrauskas, Quant. Struct.-Act. Relat. 2002, 21, 23.
63. A. K. Ghose, V. N. Viswanadhan, J. J. Wendoloski, J .Phys. Chem. A 1998, 102, 3762.
64. R. Wang, Y. Fu, L. Lai, XLOGP, Vers. 1, J. Chem. Inf. Comp. Sci. 1997, 37, 615.
65. I. V. Tetko, V. Y. Tanchuk, ALOGPs, Vers. 2.1, J. Chem. Inf. Comp. Sci. 2002, 42, 1136.
66. I. V. Tetko, J. Gasteiger, R. Todeschini, A. Mauri, D. Livingstone, P. Ertl, V. A. Palyulin, E. V. Radchenko, N. S. Zefirov, A. S. Makarenko, V. Y. Tanchuk, V. V. Prokopenko, J. Comp.-Aided Mol. Des. 2005, 19, 453.
67. I. V. Tetko, Drug Discov. Today 2005, 10, 1497.
68. M. Meloun, S.Bordovska, ACD/pKa ver. 9.04, Anal. Bioanal. Chem. 2007, 389, 1267.
69. 'AB/pKa' in Virtual Computational Chemistry Laboratory (VCCLAB, http://www.vcclab.org), 2005.
70. F. Csizmadia, J. Szegezdi, F. Darvas, in 'Trends in QSAR and Molecular Modeling 92' (Marvin-pKa, Ver. 4.1), Ed. C. G. Wermuth, ESCOM, Leiden, 1993, p. 507.
71. P. Ertl, B. Rohde, P. Selzer, J. Med. Chem. 2000, 43, 3714.
72. W. J. Hehre, 'A Guide to Molecular Mechanics and Quantum Chemical Calculations', Wavefunction, Inc., Irvine, 2003, p. 72.
73. R. Mannhold, K. Dross, Quant. Struct.-Act. Relat. 1996, 15, 403.
74. E. Deconinck, T. Hancock, D. Coomans, D. L. Massart, Y. V. Heyden, J. Pharm. Biomed. Anal. 2005, 39, 91.
75. S. Wanchana, F. Yamashita, H. Hara, S. Fujiwara, M. Akamatsu, and M. Hashida, J. Pharm. Sci. 2004, 93, 3057.
76. M. Sala-Rabanal, D. D. F. Loo, B. A. Hirayama, E. M. Wright, Am. J. Physiol. Renal Physiol. 2008, 294, F1422.
77. N. J. Snyder, L. B. Tabas, D. M. Berry, D. C. Duckworth, D. O. Spry, A. H. Dantzig, Antimicrob. Agents Chemother. 1997, 41, 1649.
78. M. E. Morris, M. A. Felmlee1, AAPS Journal 2008, 10, 311.
79. C. Shu, H. Shen, U. Hopfer, D. E. Smith, Drug Metab. Dispos. 2001, 29, 1307.
80. M. Wiese, I. K. Pajeva, Curr. Med. Chem. 2001, 8, 685.
81. K. H. Kim, Bioorg. Med. Chem. 2001, 9, 1517.
82. S. Ekins, R. B. Kim, B. F. Leake, A. H. Dantzig, E. G. Schuetz, L.-B. Lan, K. Yasuda, R. L. Shepard, M. A. Winter, J. D. Schuetz, J. H. Winkel, S. A. Wrighton, Mol. Pharmacol. 2002, 61, 964.
83. R. B. Wang, C. L. Kuo, L. L. Lien, E. J. Lien, J. Clin. Pharm. Ther. 2003, 28, 203.
84. S. Hirono, I. Nakagome, R. Imai, K. Maeda, H. Kusuhara, Y. Sugiyama, Pharm. Res. 2005, 22, 260.
85. H. Müller, I. K. Pajeva, C. Globisch, M. Wiese, Bioorg. Med. Chem. 2008, 16, 2456.
86. G. F. Ecker, T. Stockner, P. Chiba, Drug Discov. Today 2008, 13, 311.